Related Experiment Video
Updated: Feb 23, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
The Anesthetic Management for a Patient With Trisomy 13
Masanori Tsukamoto1, Takashi Hitosugi1, Kanako Esaki1
1Department of Dental Anesthesiology, Kyushu University Hospital, Fukuoka, Japan.
Insights
Trisomy 13 patients, often with severe health issues, can undergo dental treatment safely. Monitoring cardiac and seizure activity ensures successful oral care for improved quality of life.
Area of Science:
- Genetics and chromosomal abnormalities
- Pediatric medicine
- Dental medicine
Background:
- Trisomy 13 (Patau syndrome) is a severe chromosomal disorder with a poor prognosis, often leading to early mortality.
- Patients with Trisomy 13 frequently exhibit developmental delays, seizures, and congenital heart defects, impacting overall health and quality of life.
Observation:
- Special needs patients, including those with Trisomy 13 and mental retardation, often present with compromised oral health.
- This case involved a young patient with Trisomy 13, a history of ventricular septal defect closure, mental retardation, and seizures.
Findings:
- Dental treatment was successfully completed in a Trisomy 13 patient with significant comorbidities.
- Non-invasive monitoring, including cardiac electric velocimetry and epileptogenic activity assessment, ensured patient safety during dental procedures.
- Postoperative respiratory function remained stable, allowing the patient to breathe room air.
Implications:
- This case demonstrates the feasibility and safety of providing essential dental care to patients with Trisomy 13 under appropriate monitoring.
- Optimizing oral health can contribute to the overall well-being and daily functioning of individuals with severe chromosomal disorders.
- Highlights the importance of multidisciplinary care, integrating dental, cardiac, and neurological monitoring for high-risk pediatric patients.
Abstract:
Trisomy 13 is a chromosomal disorder that occurs in complete or partial mosaic forms. It is characterized by central apnea, mental retardation, seizure and congenital heart disease. The survival of the patients with trisomy 13 is the majority dying before one month. Trisomy 13 is the worst life prognosis among all trisomy syndromes. It is reported the cause of death is central apnea. Special needs patients with mental retardation are recognized to have poorer oral health condition. Oral health related quality of life reflects daily activity and well-being. Dental treatment under general anesthesia is sometimes an option for such patients. This patient had received ventricular septal defect closure surgery at 2-year-old. In addition, he had mental retardation and seizure. Dental treatment had been completed without any cerebral and cardiovascular events under non-invasive monitoring with not only cardiac electric velocimetry, but also epileptogenic activity. In addition, postoperative respiratory condition was maintained stable in room air.
Related Concept Videos
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Therapeutic Uses
Inhalational Anesthetics: Overview
Stages of General Anesthesia

